Cargando…

Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID‐19

Azithromycin (AZ) is a broad‐spectrum macrolide antibiotic with a long half‐life and a large volume of distribution. It is primarily used for the treatment of respiratory, enteric, and genitourinary bacterial infections. AZ is not approved for the treatment of viral infections, and there is no well‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damle, Bharat, Vourvahis, Manoli, Wang, Erjian, Leaney, Joanne, Corrigan, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262099/ https://www.ncbi.nlm.nih.gov/pubmed/32302411 http://dx.doi.org/10.1002/cpt.1857

Ejemplares similares

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
por: Sultana, Janet, et al.
Publicado: (2020)

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19
por: Ali, Ahmed S., et al.
Publicado: (2021)

The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin
por: Cook, Jack, et al.
Publicado: (2020)

Antiviral effects of azithromycin: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Azithromycin in the Successful Management of COVID-19: A Family Physician’s Perspective
por: Tafler, Leonid, et al.
Publicado: (2021)

The Effects of Boceprevir and Telaprevir on the Pharmacokinetics of Maraviroc: An Open-Label, Fixed-Sequence Study in Healthy Volunteers
por: Vourvahis, Manoli, et al.
Publicado: (2014)

A literature review of liver function test elevations in rifampin drug–drug interaction studies
por: Ibrahim, Sherry M., et al.
Publicado: (2022)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Azithromycin Should Not Be Used to Treat COVID-19
por: Lighter, Jennifer, et al.
Publicado: (2020)

Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Azithromycin, a questionable treatment for COVID-19
por: Belfaqeeh, O., et al.
Publicado: (2021)

Use of glucocorticoids and azithromycin in the therapy of COVID-19
por: de Lemos Neto, Miguel, et al.
Publicado: (2021)

Azithromycin through the Lens of the COVID-19 Treatment
por: Kournoutou, Georgia G., et al.
Publicado: (2022)

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
por: Okour, Malek, et al.
Publicado: (2020)

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

Azithromycin for COVID-19: More Than Just an Antimicrobial?
por: Bleyzac, Nathalie, et al.
Publicado: (2020)

Observational study of azithromycin in hospitalized patients with COVID-19
por: Rodríguez-Molinero, Alejandro, et al.
Publicado: (2020)

Reply to the letter to the editor “Azithromycin, treatment in COVID-19”
por: Manafi, Navid, et al.
Publicado: (2021)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Effects of azithromycin on ventricular repolarization in children with COVID-19
por: Sunkak, Suleyman, et al.
Publicado: (2022)

Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Pharmacological Agents with Antiviral Activity against Monkeypox Infection
por: Zovi, Andrea, et al.
Publicado: (2022)

COVID-19 from a pharmacological perspective
por: Remuzzi, Giuseppe
Publicado: (2021)

Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment
por: Toussi, Sima S., et al.
Publicado: (2022)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
por: Pani, Arianna, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p9dffhjcc461jmah4til6qu46a